• Provider Login
  • Payors
  • Manufacturers
  • Blog
  • Careers
Avella Specialty Pharmacy
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact
Menu
  • Locations
    • Retail Pharmacies
    • Mail-Order Facilities
      • Corporate Headquarters
      • National Distribution Center
      • 503A Compounding Facilities
  • Specialties
    • Addiction Management
    • Cardiovascular Disease
    • Dermatology
    • Fertility
    • Gastroenterology
    • Hepatitis
    • HIV / AIDS
    • Infusion Therapy
    • IG Therapy
    • Multiple Sclerosis
    • Oncology
    • Ophthalmology
    • Rheumatology
    • RSV
    • Transplant
    • Urology
  • Patients
    • FAQ
    • Patient Resources
  • Providers
    • Provider Portal
    • Specialties
  • Hospitals
    • 340B Program
    • 503A Oncology
  • Services
    • Adherence
    • Education
    • Financial Assistance
    • FundFinder
    • Digital Calling Card
    • Limited Distribution Drugs
    • Portal Technology
    • Prior Authorization
    • Privacy
  • About
    • Accreditations
    • Residency Program
    • Careers
    • News
    • Contact

Specialty Pharmacy Insights

Return to blog

How to Effectively Utilize Data Analytics in Specialty Pharmacy

Posted by Avella Specialty Pharmacy on Tue, Apr 22, 2014
  • Tweet

Manufacturers can become overwhelmed with specialty pharmacy data complexity. Oftentimes, the incompleteness can make the data difficult to use. The most successful approach to data analytics is based on aligning a manufacturer’s specialty pharmacy data requirements with its business needs, therapy category and pharmacy capabilities. This provides more efficient data quality management and more effective business utilization.

With the increased supply of information, data analytics should be a key function of any specialty pharmacy and practice. Tying the two together allows for reporting on-demand. By utilizing data, providers, manufacturers and payors can improve their understanding of obstacles and opportunities to improved healthcare.

Request Access to Avella's Provider Portal

How important is data analytics?: One of the highlights we want to focus on is with our relationships and partnerships with pharmacutical manufacturers. These relationships give Avella a unique opportunity to consult with manufacuters, understand their needs, and provide meaningful data and insights. This unique data provides manufacturers with meaningful information on both the medication, most importantly, the patient's response.


Watch the below video to learn what metrics are important to specialty pharmacies and practices

 
 
 
 
 
1:25
 
 
 
1:25
 
 
 
  • Speed
    1x
  • Quality
    720p
 
 
 
 
 
 
 
 
 
Wistia video thumbnail - Data Insights
About WistiaReport a problem

Thanks for reporting a problem. We'll attach technical data about this session to help us figure out the issue. Which of these best describes the problem?

Any other details or context?

 
Cancel
message
 
 
 
 
 
 
 

 
How do we use that data?: The importance of data isn't just having it, but also making sure it is used effectively to provide manufacturers, payors and providers with the clinical information they need. To do this, we work with our Clinical Affairs team that have subject matter expertise by disease category. This allows us to provide critical insights and analytics to manufacturers allowing them to take further action based on the patient's response.  

How can you start to leverage data analytics?: Our provider portal is designed to provide an integrated and holistic approach to data that will allow providers to access this unique patient and drug data, all on a HIPAA-secure platform. This allows providers to get the feedback and reports they need to see how their work, along with the work of Avella, is driving adherence for their patients.

Request Access to the Provider Portal 

Topics Avella Managed Care

CONNECT WITH US

  • social-twitter
  • social-linkedin
  • social-youtube
  • social-facebook
  • social-yelp

Subscribe For Updates

Recent Posts

Posts by Topic

  • Avella (28)
  • Oncology (23)
  • Specialty Pharmacy (18)
  • Hepatitis (14)
  • Adherence (12)
  • HIV/AIDS (6)
  • Medication (6)
  • Cancer (5)
  • Fertility (5)
  • limited distribution drugs (4)
  • Accreditations (3)
  • Patients (3)
  • Public Health (3)
  • Addiction Management (2)
  • Pain Management (2)
  • mobile health (2)
  • 340b Program (1)
  • Complex Disease (1)
  • Dermatology (1)
  • IG Therapy (1)
  • In the News (1)
  • Inc (1)
  • Inc 5000 (1)
  • Industry News (1)
  • Infusion Therapy (1)
  • LLS (1)
  • Managed Care (1)
  • Partners (1)
  • Pharmacist (1)
  • Psoriasis (1)
  • RSV (1)
  • Rheumatoid Arthritis (1)
  • outsourcing facility (1)
  • payers (1)
see all
  • specialty_accreditation_seal-1
  • rsz_mail_service_accreditationseal
  • Addiction Management
  • Cardiovascular Disease
  • Dermatology
  • Fertility
  • Gastroenterology
  • Hepatitis
  • HIV / AIDS
  • Infusion Therapy
  • IG Therapy
  • Multiple Sclerosis
  • Oncology
  • Ophthalmology
  • Rheumatology
  • RSV
  • Transplant
  • Urology
  • Contact Avella
  • Terms of Use
  • Privacy
  • Blog
  • 877-546-5779
© 2025 Avella Specialty Pharmacy
  • Twitter
  • LinkedIn
  • YouTube
  • Facebook
.